Evidence map›Paper›PMID 42214299›Full record

ArticleAddictive behaviors2026

Modes of cannabis administration, cannabis and tobacco co-use, and associations with respiratory and cannabis use outcomes in a permissive medical cannabis state.

Amy Cohn, Katelyn F Romm, Erin A Vogel, Steven Pan, Summer G Frank-Pearce, Michael A Smith, Hannah Appleseth, Laili Boozary, Munjireen S Sifat, Darla E Kendzor

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Addictive behaviors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Amy CohnTSET Health Promotion Research Center, University Oklahoma Health Sciences Center, Stephenson Cancer Center, 655 Research Parkway, Suite 400, Oklahoma City, Oklahoma 73104, USA; Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA. Electronic address: amy-cohn@ouhsc.edu.
Katelyn F RommTSET Health Promotion Research Center, University Oklahoma Health Sciences Center, Stephenson Cancer Center, 655 Research Parkway, Suite 400, Oklahoma City, Oklahoma 73104, USA; Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Erin A VogelTSET Health Promotion Research Center, University Oklahoma Health Sciences Center, Stephenson Cancer Center, 655 Research Parkway, Suite 400, Oklahoma City, Oklahoma 73104, USA; Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Steven PanTSET Health Promotion Research Center, University Oklahoma Health Sciences Center, Stephenson Cancer Center, 655 Research Parkway, Suite 400, Oklahoma City, Oklahoma 73104, USA; Department of Biostatistics and Epidemiology, Hudson College of Public Health, University of Oklahoma Health Sciences, Oklahoma City, Oklahoma, USA.
Summer G Frank-PearceTSET Health Promotion Research Center, University Oklahoma Health Sciences Center, Stephenson Cancer Center, 655 Research Parkway, Suite 400, Oklahoma City, Oklahoma 73104, USA; Department of Biostatistics and Epidemiology, Hudson College of Public Health, University of Oklahoma Health Sciences, Oklahoma City, Oklahoma, USA.
Michael A SmithTSET Health Promotion Research Center, University Oklahoma Health Sciences Center, Stephenson Cancer Center, 655 Research Parkway, Suite 400, Oklahoma City, Oklahoma 73104, USA.
Hannah ApplesethTSET Health Promotion Research Center, University Oklahoma Health Sciences Center, Stephenson Cancer Center, 655 Research Parkway, Suite 400, Oklahoma City, Oklahoma 73104, USA.
Laili BoozaryTSET Health Promotion Research Center, University Oklahoma Health Sciences Center, Stephenson Cancer Center, 655 Research Parkway, Suite 400, Oklahoma City, Oklahoma 73104, USA.
Munjireen S SifatDepartment of Medical Oncology, Population Health Science Division, Sidney Kimmel Medical College, Thomas Jefferson University, USA.
Darla E KendzorTSET Health Promotion Research Center, University Oklahoma Health Sciences Center, Stephenson Cancer Center, 655 Research Parkway, Suite 400, Oklahoma City, Oklahoma 73104, USA; Department of Family and Preventive Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Funding

Tissue Pathology Shared ResourceP30CA225520 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI ROBERT S. MANNEL · 2018 to 2026
$27.1M
NCI NIH HHS P30 CA225520
6 · The paper itself

Abstract

objectiveThis study assessed differences in the prevalence and correlates of different cannabis modes of administration (MOAs) between those reporting co-use (past 30-day nicotine/tobacco and cannabis use and or cannabis-only use.

methodParticipants were adults reporting past 30-day cannabis use (n=3,488) who provided data for a repeated cross-sectional online survey (September 2020-September 2024). Prevalence and relative rankings of past 30-day use of nine different cannabis MOAs (smoking, vaping, dabbing, eating, drinking, oil, lotion, dissolvable, blunt use) were examined across past those reporting 30-day cannabis-only use and co-use. ANCOVA tests examined associations of co-use (vs cannabis-only use) and past 30-day combustible MOA use (combustible-only, non-combustible-only, both) with respiratory problems and past 30-day frequency of medical and recreational cannabis use.

resultsSmoking cannabis was the most common MOA among cannabis-only (72%) and co-users (83.1%). Among those reporting co-users, blunt use was the second most popular MOA (64.8%), then vaping (44%), and then edibles (36.5%). In the cannabis-only group, edibles were the second most common MOA (47.8%), then blunt use (36.1%), and vaping (33.4%). Combustible MOA use and co-use (vs cannabis-only use) were associated with more severe respiratory problems and more frequent medical and recreational cannabis in the past 30-days. Conclusions Those who co-use nicotine/tobacco with cannabis and those consuming combustible MOAs may be at increased risk of health consequences and more frequent cannabis use.

Indexed as

Marijuana SmokingMedical MarijuanaTobacco UseAdolescentAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedPrevalenceVapingYoung AdultMedical Marijuanabluntcannabiscombustiblemedicalmodes of userecreationalrespiratory problemsvaping

Identifiers

PMID42214299
PMCPMC13343724

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.